The Stanton Schwartz syndrome: three cases.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to H C Denber.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
This was a 1-year study of fluvoxamine in 31 depressed male and female patients with a history of chronic recurring depression of various types. Fluvoxamine has a rapid action with lifting of the mood often within 4-7 days, in a dosage range from 150 to 200 mg/day. Suicidal ideation in 8 patients disappeared within 5-6 days. There were few side effects. This new antidepressant seemed to be very effective especially in endogenous depression.
Anxiolytic and neuroleptic drugs offer a pharmacotherapeutic approach to the treatment of anxiety. A proper diagnosis and a complete understanding of the clinical picture is essential before choosing the class, specific drug, and dosage. Anxiolytics may be used in the neuroses and as adjuncts in other disorders (ex. depression) with a strong anxiety component. Neuroleptics, in very low dosage, are indicated for psychotic anxiety. Dosage, side effects, and duration of treatment must be monitored continuously. Concomitant psychotherapy is advisable.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
This article focuses on the treatment of depression with special reference to pharmacotherapy. The treatment-resistant case and the possible means of resolving its problems are highlighted. The role of ECT will be considered. Long-term maintenance treatment with antidepressant medication for patients with cyclic occurrences is recommended.
Explore the source record for details and available documents.
This is a preliminary report concerning a new antidepressant, SKF 28,175 which is neither an IMAO nor does it have the usual tricyclic structure, retaining the CF 3 at the number two position on the ring. It was studied in 27 male and female patients. The drug was highly effective, within 4-7 days for the most part, as confirmed by statistical analysis of the Hamilton Rating Scale. There were relatively few side effects. Only one dosage per day, in the evening, was required.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.